KRYS
Krystal Biotech is a gene therapy biotechnology company focused on developing and delivering medicines for genetic skin diseases using an HSV-1 based gene delivery platform. The company aims to treat patients with life-threatening or rare conditions by applying redosable gene therapies and advancing a pipeline of genetic medicines. Krystal Biotech operates primarily in the United States with a focus on dermatologic genetic diseases and related manufacturing and clinical development activities.
No recent news for this company.